<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">1246405</journal-id>
<journal-id journal-id-type="pubmed-jr-id">2835</journal-id>
<journal-id journal-id-type="nlm-ta">Cell Immunol</journal-id>
<journal-id journal-id-type="iso-abbrev">Cell. Immunol.</journal-id>
<journal-title-group>
<journal-title>Cellular immunology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0008-8749</issn>
<issn pub-type="epub">1090-2163</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28449847</article-id>
<article-id pub-id-type="pmc">5515728</article-id>
<article-id pub-id-type="doi">10.1016/j.cellimm.2017.04.001</article-id>
<article-id pub-id-type="manuscript">NIHMS871385</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Loss of WDFY3 Ameliorates Severity of Serum Transfer-Induced Arthritis Independently of Autophagy</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Wu</surname>
<given-names>Dennis J.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="aff" rid="A2">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Adamopoulos</surname>
<given-names>Iannis E.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="aff" rid="A2">b</xref>
<xref ref-type="aff" rid="A3">c</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>a</label>Graduate Group in Immunology, University of California at Davis</aff>
<aff id="A2">
<label>b</label>Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis</aff>
<aff id="A3">
<label>c</label>Institute for Pediatric Regenerative Medicine, Shriners Hospitals for Children, Northern California</aff>
<author-notes>
<corresp id="FN1"><label>*</label><bold>Correspondence:</bold> Iannis E. Adamopoulos, Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis, Institute for Pediatric Regenerative Medicine, Shriners Hospitals for Children Northern California, 2425 Stockton Blvd, Sacramento, CA, 95817, USA. Tel: 916-453 2237 Fax: 916-453 2288. <email>iannis@ucdavis.edu</email></corresp>
<fn fn-type="COI-statement" id="FN3">
<p id="P21">
<bold>Conflict of interest</bold>
</p>
<p id="P22">None of the authors has any potential financial conflict of interest related to this manuscript.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>11</day>
<month>5</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>22</day>
<month>4</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>6</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>6</month>
<year>2018</year>
</pub-date>
<volume>316</volume>
<fpage>61</fpage>
<lpage>69</lpage>
<!--elocation-id from pubmed: 10.1016/j.cellimm.2017.04.001-->
<abstract>
<p id="P1">WDFY3 is a master regulator of selective autophagy that we recently showed to interact with TRAF6 and augment RANKL-induced osteoclastogenesis <italic>in vitro</italic> and <italic>in vivo</italic> via the NF-κB pathway. Since the NF-κB pathway plays a major role in inflammation herein, we investigate the role of WDFY3 in an arthritis animal model. Our data show that WDFY3 conditional knockout mice (<italic>Wdfy3<sup>loxP/loxP</sup>-LysM-Cre+</italic>,) were protected in the K/BxN serum transfer-induced arthritis animal model. These effects were independent of alterations in starvation-induced autophagy as evidenced by Western blot analysis of the autophagy marker LC3, autophagosome formation in osteoclast precursors and lysosome formation in osteoclasts derived from <italic>WDFY3-cKO</italic> mice compared to controls. Moreover, we demonstrate by immunofluorescence and co-immunoprecipitation that WDFY3 interacts with SQSTM1 in macrophages and osteoclasts. Collectively, our data suggest that loss of WDFY3 in myeloid cells leads to reduced severity of inflammatory arthritis independently of WDFY3 function in starvation-induced autophagy.</p>
</abstract>
<kwd-group>
<kwd>Autophagy</kwd>
<kwd>Autophagy-linked FYVE containing protein</kwd>
<kwd>ALFY</kwd>
<kwd>WDFY3</kwd>
<kwd>osteoclast</kwd>
<kwd>musculoskeletal diseases</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>